3,5-Dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline

We are 3,5-Dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline CAS:104147-32-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3,5-Dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline
CAS.NO:104147-32-2
Synonyms:3,5-Dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline
 
Physical and Chemical Properties:
Density 1.558
Boiling Point 305ºC
Molecular Formula C8H5Cl2F4NO
Molecular Weight 278.03100
Flash Point 138ºC
Vapour Pressure 0.000834mmHg at 25°C
Index of Refraction 1.496
 
Specification:
Appearance:White to off-white crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Hexaflumuron(CAS:86479-06-3).

3,5-Dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline


Related News: Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.58045-41-3 Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.Ácido 2-cloro-3-fluorobenzoico CAS:102940-86-3 Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.2-thioladenosine The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.

Related Products
Product Name
2-chloro-N-(2,6-diethylphenyl)acetamide View Details
(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol View Details
3-Heptylacrolein View Details
DSIP manufacturer 4-(Trans-4-pentylcyclohexyl) phenyl boronic acid manufacturer 4-Bromo-2-fluoro-1-(trifluoromethoxy)benzene manufacturer Dimethoxydiphenylsilane manufacturer 2-ethoxynaphthalene-1-carboxylic acid manufacturer